Lani, that would be a different study... ?????
When Herceptin is used in the adjuvant setting, does Herceptin delay or prevent the onset of metastasis over n periods of time? (criteria separated by type of bc, pre vs postmenopausal, ER+ vs ER-, bc stages, etc),
OMG, wouldn't knowing that answer be so grand !
With your network/contacts, is it possible you could find out if any researchers are working on this, or could you possibly suggest Genentech agree to responsibility for coordinating this, or could you offer the suggestion to any other potential researchers?
We HER2ers could even participate in the study/survey.
Joanne S
I am anxious to find out about the results of HERA III trail related to 1 vs 2 year administeration of Herceptin.
|